Evaluation of novel LCI CAD EYE system for real time detection of colon polyps von Neumann, Helmut, Kreft, Andreas, Sivanathan, Visvakanth, Rahman, Fareed, Galle, Peter R

Volltext

Local and Regional Therapies for Hepatocellular Carcinoma von Kloeckner, Roman, Galle, Peter Robert, Bruix, Jordi

Volltext

Systemic treatment of hepatocellular carcinoma: An EASL position paper von Bruix, Jordi, Chan, Stephen L., Galle, Peter R., Rimassa, Lorenza, Sangro, Bruno

Volltext

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma von Cheng, Ann-Lii, Qin, Shukui, Ikeda, Masafumi, Galle, Peter R., Ducreux, Michel, Kim, Tae-You, Lim, Ho Yeong, Kudo, Masatoshi, Breder, Valeriy, Merle, Philippe, Kaseb, Ahmed O., Li, Daneng, Verret, Wendy, Ma, Ning, Nicholas, Alan, Wang, Yifan, Li, Lindong, Zhu, Andrew X., Finn, Richard S.

Volltext

Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma von Sangro, Bruno, Chan, Stephen L., Meyer, Tim, Reig, María, El-Khoueiry, Anthony, Galle, Peter R.

Volltext

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update von Reig, Maria, Forner, Alejandro, Rimola, Jordi, Ferrer-Fàbrega, Joana, Burrel, Marta, Garcia-Criado, Ángeles, Kelley, Robin K., Galle, Peter R., Mazzaferro, Vincenzo, Salem, Riad, Sangro, Bruno, Singal, Amit G., Vogel, Arndt, Fuster, Josep, Ayuso, Carmen, Bruix, Jordi

Volltext

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma von Finn, Richard S, Qin, Shukui, Ikeda, Masafumi, Galle, Peter R, Ducreux, Michel, Kim, Tae-You, Kudo, Masatoshi, Breder, Valeriy, Merle, Philippe, Kaseb, Ahmed O, Li, Daneng, Verret, Wendy, Xu, Derek-Zhen, Hernandez, Sairy, Liu, Juan, Huang, Chen, Mulla, Sohail, Wang, Yulei, Lim, Ho Yeong, Zhu, Andrew X, Cheng, Ann-Lii

Volltext

Systemic therapy of advanced hepatocellular carcinoma von Galle, Peter R, Dufour, Jean-François, Peck-Radosavljevic, Markus, Trojan, Jörg, Vogel, Arndt

Volltext

Molecular Structure, Chemical Exchange, and Conductivity Mechanism of High Concentration LiTFSI Electrolytes von Galle Kankanamge, Susith R, Kuroda, Daniel G

Volltext

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled,... von Zhu, Andrew X, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S, Galle, Peter R, Llovet, Josep M, Assenat, Eric, Brandi, Giovanni, Pracht, Marc, Lim, Ho Yeong, Rau, Kun-Ming, Motomura, Kenta, Ohno, Izumi, Merle, Philippe, Daniele, Bruno, Shin, Dong Bok, Gerken, Guido, Borg, Christophe, Hiriart, Jean-Baptiste, Okusaka, Takuji, Morimoto, Manabu, Hsu, Yanzhi, Abada, Paolo B, Kudo, Masatoshi

Volltext

Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase... von Galle, Peter R, Finn, Richard S, Qin, Shukui, Ikeda, Masafumi, Zhu, Andrew X, Kim, Tae-You, Kudo, Masatoshi, Breder, Valeriy, Merle, Philippe, Kaseb, Ahmed, Li, Daneng, Mulla, Sohail, Verret, Wendy, Xu, Derek-Zhen, Hernandez, Sairy, Ding, Beiying, Liu, Juan, Huang, Chen, Lim, Ho Yeong, Cheng, Ann-Lii, Ducreux, Michel

Volltext

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma von Bridgewater, John, Galle, Peter R, Khan, Shahid A, Llovet, Josep M, Park, Joong-Won, Patel, Tushar, Pawlik, Timothy M, Gores, Gregory J

Volltext

Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma von Galle, Peter R., Foerster, Friedrich, Kudo, Masatoshi, Chan, Stephen L., Llovet, Josep M., Qin, Shukui, Schelman, William R., Chintharlapalli, Sudhakar, Abada, Paolo B., Sherman, Morris, Zhu, Andrew X.

Volltext

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum prog... von Moehler, M, Maderer, A, Schimanski, C, Kanzler, S, Denzer, U, Kolligs, F.T, Ebert, M.P, Distelrath, A, Geissler, M, Trojan, J, Schütz, M, Berie, L, Sauvigny, C, Lammert, F, Lohse, A, Dollinger, M.M, Lindig, U, Duerr, E.M, Lubomierski, N, Zimmermann, S, Wachtlin, D, Kaiser, A.-K, Schadmand-Fischer, S, Galle, P.R, Woerns, M

Volltext

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference von Llovet, Josep M., Villanueva, Augusto, Marrero, Jorge A., Schwartz, Myron, Meyer, Tim, Galle, Peter R., Lencioni, Riccardo, Greten, Tim F., Kudo, Masatoshi, Mandrekar, Sumithra J., Zhu, Andrew X., Finn, Richard S., Roberts, Lewis R.

Volltext

Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma von Gerbes, Alexander, Zoulim, Fabien, Tilg, Herbert, Dufour, Jean-François, Bruix, Jordi, Paradis, Valérie, Salem, Riad, Peck-Radosavljevic, Markus, Galle, Peter R, Greten, Tim F, Nault, Jean-Charles, Avila, Matias A

Volltext

A comprehensive model of the spatio-temporal stem cell and tissue organisation in the intestinal crypt von Buske, Peter, Galle, Jörg, Barker, Nick, Aust, Gabriela, Clevers, Hans, Loeffler, Markus

Volltext

The unequal effects of trade and automation across local labor markets von Galle, Simon, Lorentzen, Linnea

Volltext

Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease von Kiesslich, R, Duckworth, C A, Moussata, D, Gloeckner, A, Lim, L G, Goetz, M, Pritchard, D M, Galle, P R, Neurath, M F, Watson, A J M

Volltext

Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond von Raoul, Jean-Luc, Kudo, Masatoshi, Finn, Richard S., Edeline, Julien, Reig, Maria, Galle, Peter R.

Volltext